ViroGates A/S (VIRO) - Total Liabilities

Latest as of September 2025: Dkr11.38 Million DKK ≈ $1.78 Million USD

Based on the latest financial reports, ViroGates A/S (VIRO) has total liabilities worth Dkr11.38 Million DKK (≈ $1.78 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does ViroGates A/S generate cash to assess how effectively this company generates cash.

ViroGates A/S - Total Liabilities Trend (2015–2024)

This chart illustrates how ViroGates A/S's total liabilities have evolved over time, based on quarterly financial data. See VIRO book value for net asset value and shareholders' equity analysis.

ViroGates A/S Competitors by Total Liabilities

The table below lists competitors of ViroGates A/S ranked by their total liabilities.

Company	Country	Total Liabilities
In8bio Inc NASDAQ:INAB	USA	$3.48 Million
Turbo Mech Bhd KLSE:5167	Malaysia	RM11.90 Million
Javelin Minerals Ltd AU:JAV	Australia	AU$1.37 Million
Overactive Media Corp V:OAM	Canada	CA$21.11 Million
Nusantara Almazia JK:NZIA	Indonesia	Rp87.37 Billion
Marwynn Holdings, Inc. Common stock NASDAQ:MWYN	USA	$454.03K
Elicera Therapeutics AB ST:ELIC	Sweden	Skr6.97 Million
Vinpai SAS PA:ALVIN	France	€10.77 Million

Liability Composition Analysis (2015–2024)

This chart breaks down ViroGates A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of ViroGates A/S.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.80	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ViroGates A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ViroGates A/S (2015–2024)

The table below shows the annual total liabilities of ViroGates A/S from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	Dkr6.87 Million ≈ $1.07 Million	-9.05%
2023-12-31	Dkr7.55 Million ≈ $1.18 Million	+420.19%
2022-12-31	Dkr1.45 Million ≈ $227.02K	-61.85%
2021-12-31	Dkr3.80 Million ≈ $595.01K	-45.14%
2020-12-31	Dkr6.93 Million ≈ $1.08 Million	+135.62%
2019-12-31	Dkr2.94 Million ≈ $460.30K	+21.97%
2018-12-31	Dkr2.41 Million ≈ $377.37K	+21.76%
2017-12-31	Dkr1.98 Million ≈ $309.94K	-34.23%
2016-12-31	Dkr3.01 Million ≈ $471.25K	-0.46%
2015-12-31	Dkr3.03 Million ≈ $473.44K	--

About ViroGates A/S

CO:VIRO Denmark Medical Devices

Market Cap

$15.97 Million

Dkr102.10 Million DKK

Market Cap Rank

#25812 Global

#117 in Denmark

Share Price

Dkr11.00

Change (1 day)

+4.76%

52-Week Range

Dkr7.80 - Dkr17.40

All Time High

Dkr238.00